abs343.txt	background		statin	use	is	associated	with	lower	advanced	prostate	cancer	risk	andreduced	cancer-specific	mortality	but	prior	studies	were	conductedmainly	in	white	men	we	examined	the	effect	of	on	prostatecancer	progression	a	population-based	minority-enriched	cohort	methods	used	data	from	cases	(45%	african	american)	diagnosedbetween	2004	and	2007	who	participated	health	care	access	treatment	north	carolina	(hcap-nc)	abstracted	atdiagnosis	reported	if	they	had	ever	been	diagnosed	high	cholesterol	multivariable	cox	proportional	hazards	analysis	was	to	examine	associationsbetween	(biochemicalrecurrence	or	secondary	treatment)	overall	by	race	association	between	results	669	244	(36%)	users	at	diagnosis	during	3	8	yearsmedian	follow-up	138	experienced	there	noassociation	either	(hr	1	03	95%ci	0	72-1	46)	stratified	inversely	associatedwith	particularly	among	43	95%ci0	20-0	94	p-interaction	=	22)	higher	perceived	care(hr	57	36-0	90	03)	study	limitations	included	arelatively	small	sample	size	short	lack	regarding	postdiagnosis	conclusions	not	cancerprogression	hcap-nc	greaterhealthcare	engagement	including	actively	controlling	serum	may	belinked	better	outcomes
